The band 4.1 domain was first identified in the red blood cell protein band 4.1, and subsequently in ezrin, radixin, and moesin (ERM proteins) and other proteins, including tumor suppressor merlin/schwannomin, talin, unconventional myosins VIHa and X, and protein tyrosine phosphatases. Recently, the presence of a structurally related domain has been demonstrated in the N-terminal region of two groups of tyrosine kinases: the focal adhesion kinases (FAIK) and the Janus kinases (JAK). Additional proteins containing the 4
Introduction
Attachment of proteins to membranes is necessary for the organization of cell structure, providing each cell with its characteristic shape and its capacity for movement. Work during the last decade has demonstrated that protein targeting to the membrane is also critical for signal transduction (1) . The activation of a number of signaling pathways begins with the highly regu-lated aggregation of specific proteins at the level of the membrane, allowing the initiation of cascades of enzymatic reactions. Thus, the study of the mechanisms responsible for membrane targeting of cytoplasmic proteins has become a fertile area of research. Many proteins have covalently attached fatty acids including palmitate, myristate, and isoprenoid derivatives, which can themselves be inserted in the lipidic bilayer (2) . In some cases these interactions are regulated and proteins can cycle from a soluble to a membrane-bound state. Specific protein domains can also interact noncovalently with membrane phospholipids using pleckstrin homology (PH) domains, which bind phosphatidylserine polyphosphates (3) , or C2 domains, which bind phosphatidylserine in the presence of Ca2+ (4) . Membrane targeting of cytoplasmic proteins is also achieved by interaction of specific domains, including PSD-95/Dlg/Zo-1 (PDZ), WH1/EVH1, and death domains, with transmembrane proteins (5, 6) . SH2 and phosphotyrosine binding (PTB) domains play an important role by interacting with membrane-associated proteins when they are phosphorylated on tyrosine (7) . Interestingly, the roles of lipids and proteins in membrane targeting are not separated, since phospholipids can regulate protein-protein interactions directly or indirectly (8) . Moreover, some domains can interact with both lipids and proteins. One example is the PH domains that interact with phosphoinositides and with f3/y subunits of heterotrimeric G proteins (3, 9) .
The band 4.1 domain is a large (>300 residues) and relatively less characterized domain, capable of interaction with several types of proteins including transmembrane proteins, and in some cases with lipids (10, 11) . This domain was originally identified as the N-terminal chymotrypsin-resistant region of erythrocyte protein band 4.1, which is capable of binding to glycophorin C (12, 13) . It was then recognized in three related proteins, ezrin, radixin, and moesin (ERM), which also act as linkers between the actin cytoskeleton and the plasma membrane (10) . The band 4.1 domain is present in many proteins (14, 15) (Fig. 1) . The acronym FERM (Four-point-one/Ezrin/Radixin/Moesin) has been suggested to refer to this domain (14) . However, recent work has extended considerably the significance of the band 4.1 domain, showing that, despite a low level of sequence identity, significant structural relationships exist between the N-terminal region of focal adhesion kinases (FAK) and Janus kinases (JAK) (15) . A relationship between the band 4.1 domain and FAK N-terminal region was also reported independently by means of a different approach (16) . In this review, we will use the term band 4.1 /JEF (JAK-ERM-FAK) to refer to this domain. We shall summarize the approaches that allowed identification of the relationship between the distant members of the band 4.1 /JEF superfamily and the structural characteristics of this domain. Some features of the various proteins containing band 4.1 /JEF domains and of their known partners are reviewed, and their common properties outlined. Finally, we shall indicate the importance of the mutations of these domains in human pathology.
Sequence and Structural Features of the Band 4.1/JEF Domain Superfamily
The band 4.1 domain has been defined on the basis of sequence similarities easily detected by automatic procedures such as BLAST or FASTA. This allowed the identification of its presence in ERM and proteins such as protein tyrosine phosphatases, talin, and unconventional myosins (10, 14) . However, the recognition of this domain in the N termini of FAK and JAK (15) was not possible by this approach and required the use of a bidimensional method of sequence analysis called hydrophobic cluster analysis (HCA) (17, 18) . The sensitivity of HCA within and below the twilight zone (i.e., -25-30% sequence identity) originates from its ability to combine sequence comparison with secondary structure prediction. Indeed, the clusters formed by hydrophobic amino acids on the HCA bidimensional plot (Fig. 2) have been shown to correspond mainly to the internal faces of regular secondary structures in globular proteins (19) . They constitute two-dimensional (2D) signatures that are much more stable, and therefore recognizable through human expertise, than signatures described from ID sequence only (20) . Therefore, at low levels of sequence identity, the method is particularly efficient in detecting similar folds by sorting out true relationships from background noise (18) .
The starting point of the analysis was the finding of a close relationship between the Nterminal sequence of FAK and an uncharacterized human gene product termed KIAA03 16 (15) . This finding was decisive since, although clearly belonging to the FAK group (Fig. 3) (Fig. 3) . On the other hand, the FAK group was also found to be related to the N-terminal sequence of JAKs. This latter group is distinguished by the long sequences that separate conserved blocks in the alignment of band 4.1 /JEF domains ( Fig. 2a ) (1 5 :-----mouse NBL4
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: (Fig. 2b) . Sequence conservation (e.g., -13% sequence identity in the case of ER>`/ ) and h',-drophobic cluster conservation are observed between the two putative subdomains. The hypothesis of a duplication is further supported by similar secondary structure predictions. Comparison of the sequence of the two putative subdomains highlights short conserved sequence motifs that are predicted to be related to the core structure of the domain or a key conserved function. These motifs, including the stretches lxii g/n, wixid and III/qi+ (where / stands for an hydrophobic residue; +, a positively charged residue; g, a glycine residue; q, a glutamine residue; w, a tryptophan residue; and x, a variable position) are all associated with predicted buried ,3 strands. The evidence for an internal duplication is clear within the 4.1 /ERM group and in the case of KIAA0316 (data not shown). -Hlowever, it is much less conspicuous in the FAK and JAK groups, suggesting that the two subdomains have undergone a divergent evolution in these tyrosine kinases.
Proteins with Band 4.1/PEF Domains and Their Partners Band 4.1 and Related Proteins Band 4.1 contains a C-terminal actin/spectrin binding-domain and thus acts as a cross-linker between the cortical cytoskeleton and the membrane of eryth-ocytes, playing a critical -ole in the characteristic shape of these cells (12) . The membrane partners of band 4.1 have been extensively studied. The main anchor site is the short intracellular C-terminal tail of glycophorin C, a small transmembrane protein with a heavily glycosylated extracellular domain. The band 4.1 binding site of glycophorin C has been mapped precisely (21, 22) (Fig. 4a) . The N-terminal domain of erythrocyte band 4.1 binds also to the anion exchanger of erythrocyte membrane (band 3) (23) and to CD44, first identified as an anchoring site for ERM proteins (see below) (24) . The interaction may involve a stretch of arginine residues in band 3 and acidic residues (LEEDY) in band 4.1 (25) (Fig. 4b) . Another important partner of the band 4.1 /JEF domain in red blood cells is the protein p55, which contains a PDZ, a SH3, and a guanylate-kinase domain and belongs to the MAGUK (membrane associated-guanylate kinases) family of proteins (21) . p55 is capable of binding simultaneously the band 4.1 /JEF domain by a short region between its SH3 and guanylate kinase domains (Fig. 4b ) and the C terminus of glycophorin C by its PDZ domain (26, 27) (Fig. 5a ). Thus, a ternary complex between glycophorin C, band 4.1, and p55 may be a basic structural component allowing anchorage of the cortical cytoskeleton to the erythrocyte membrane (Fig. Sa) . The sequence in p55 responsible for band 4.1 binding is conserved in Drosophila disc-large protein (Dlg) and its human homologue (H-dlg), which suggests that such interactions have been conserved during evolution (21) . The formation of membraneassociated complexes containing band 4.1 is probably highly regulated, since the binding of band 4.1 to glycophorin C is increased by phosphatidylinositol 4, 5-bisphosphate (PIP2) (13), whereas Ca2+/calmodulin reduces its affinity for CD44 (24) .
The role of band 4.1 is not restricted to erythrocytes. In fact, a number of different 4.1 proteins with distinct patterns of tissue expression and different intracellular localizations are generated from the same gene, as a result of two different sites of initiation of transcription and multiple alternatively spliced exons (28, 29) . In addition, several other genes code for related proteins. One of them is an ubiquitously expressed 4.1-G (general protein 4.1) which was identified as a protein interacting with FKBP-13 of the immunophilin family (30) . Other as-yet uncharacterized gene products with high sequence similarity to band 4 (33, 38) . It has been proposed that other neurexins (I-III), which have some sequence similarity with the band 4.1-binding region of glycophorin C and paranodin (Fig. 4a) , might also be band 4.1-binding proteins (39) . This is an interesting possibility, which should be experimentally tested, since CASK, a MAGUK protein, is also associated with neurexins (40) and binds to band 4.1 (41) . Proteins related to band 4.1 are probably attached to a number of transmembrane proteins with different extracellular domains but with a conserved intracellular segment. A tentative consensus binding site for band 4.1, the GNP motif (Glycophorin C, Neurexin IV, Paranodin), can be built by comparing sequences of the three proteins that have been shown to interact with band 4.1 (Fig. 4a) . Using the BLAST screening program (42), we were able to find a similar motif in the membrane-proximal C-terminal region of several novel transmembrane proteins (Fig. 4a) x >4 " .. Ezrin, radixin, and moesin are three related proteins of -80 kDa that have an N-terminal band 4.1 /JEF domain and the ability to bind actin (10, 11, 43) . Although there are some sequence differences in their C-terminal moiety (e.g., ab- brane ruffles, and cell contacts (10, 11, 43) . They bind actin through their C terminus and, possibly, two additional sites, at the N terminus and in the band 4.1 domain (res. 281-333) (44) . The ERM proteins can interact with CD44, a large and ubiquitous transmembrane glycoprotein, which acts as a receptor for hyaluronic acid, collagen, fibronectin, and serglycin (45) (Fig. 5b) . ERM proteins can bind to other transmembrane proteins that have a more restricted pattern of expression such as CD43 and intercellular cell adhesion molecules (ICAM) 2 and 3 (46, 47) .
ERM proteins also co-localize with the H+/K+ ATPase and are associated with EBP-50/NHE-RF, a protein with two PDZ domains that regulates the Na+/H+ exchanger (48, 49) . In addition, ERM proteins bind to Rho-GDI and reduce its activity, thereby initiating the activation of Rho (50) . This observation may be related to the requirement of ERM proteins for the Rho-induced stress fibers formation (51) .
ERM proteins have a long a-helical region with the ability to form coiled-coil interactions and regions of intramolecular recognition in the N and C termini (52, 53) . These features lead to intra-or intermolecular head-to-tail interactions that are thought to maintain the ERM proteins in a closed conformation as inactive monomers or to provide the basis for dimerization ( 11, 43) . Several regulatory factors contributing to the activation of ERM proteins have been reported. ERM proteins contain a conserved tyrosine phosphorylation site that might be involved in the regulation of oligomerization (54) . PIP2 binds to the N-terminal band 4.1 domain of ERM proteins and promotes their interaction with CD44 in vitro (55, 56) . The action of Rho-GTP is necessary for the binding of ERM proteins to CD44 (56) . One possible mechanism of action of Rho is the activation of Rho-kinase and the phosphorylation of ERM proteins on a conserved C-terminal threonine, which prevents the head-to-tail interaction (57) (Fig. 5b) .
Schwannomin/Merlin
The gene mutated in neurofibromatosis type 2 (NF2) codes for a tumor suppressor termed schwannomin (58) or merlin (moesin-ezrin-radixin-like protein) (59) that has a high degree of sequence identity with ERM proteins (43% overall identity with ezrin, 62% in the band 4.1 Nterminal domain). Schwannomin is co-localized with cortical actin (60) (61) (62) and is enriched in membrane ruffles (63) . Although it lacks the C-terminal actin-binding domain of ERM proteins, schwannomin may bind actin by its Nterminal domain (res. 178-367) (64) and one of its splice isoforms (isoform 2) interacts with spectrin by its C-terminal domain (65) . Schwannomin also interacts with CD44 (60), microtubules (64), and EBP-50 (48) . In Drosophila, homologues of moesin (D-moesin) and merlin/ schwannomin (D-merlin) are both associated with the plasma membrane but the latter appears to be co-localized with the endocytic compartment (66 (Fig. 1) (73,74) . The presence of band 4.1 domains might give these proteins a mode of membrane association unique among the unconventional myosins. In addition, myosin X contains PH domains, which may also contribute to their membrane attachment. Myosin Vlla is enriched in stereocilia of cochlear and vestibular sensory cells and is necessary for the integrity and function of these cells (74) . Band 4.1/JEF domains are also found in a specific group of microtubule-associated proteins related to the kinesin family in plants. Kinesin In contrast, the band 4.1/JEF domain of a third grou-of PTP is more divergent (Fig. 3) . These phosphatases, known as PTP-BAS (84) (91, 92) . The knockout of FAK gene is embryonic lethal (93) . Its role is thought to include signaling from integrins, turnover of focal adhesion, anti-apoptotic effects of cell contacts with the extracellular matrix, and plasticity in the adult nervous system (94) (95) (96) . FAK is autophosphorylated in response to integrin engagement or stimulation of a number of G proteincoupled receptors (97) . The autophosphorylated tyrosine-397 binds with high affinity Src family kinases that in turn phosphorylate other residues and neighboring proteins, leading to the activation of multiple signaling pathways (98) . FAK consists of a central tyrosine kinase domain flanked by a C-terminal domain, which is the site of multiple protein-protein interactions, and an N-terminal domain whose similarity with band 4.1 domain was recently demonstrated (15, 16 Autophosphorylation of FAK on Tyr-397, which is located between the band 4.1/JEF domain and the kinase domain, is a critical step in its activation. However, the precise mechanism of this autophosphorylation is not known. It might involve a transient dimerization and an intermolecular phosphorylation, by analogy with growth factor receptors. Alternatively, it could result from the suppression of an intramolecular inhibition, as in the case of Src-family kinases, or from a combination of the two mechanisms (i.e., suppression of intramolecular inhibition leading to transphosphorylation). Accordingly, deletion of the region corresponding to the band 4.1/JEF domain increases FAK autophospho-rylation in vitro (101, 102) . Moreover, permanent membrane association by fusion of the N terminus with a trarsmembrane protein results in a constitutive activation of FAK (101) . These observations are compatible with an intramolecular inhibition by the N-terminal domain (96) . Interestingly, neuronal splice isoforms of FAK, which differ from the ubiquitous form by the insertion of short peptides on both sides of tyrosine-397, have a dramatically increased autophosphorylation, suggesting that slight modifications in the peptide joining the kinase domain and the band 4.1 /JEF domain and containing the autophosphorylation site have important consequences for activation of the enzyme (103) . Thus, FAK is targeted to focal adhesions by its C-terminal region, whereas the N-terminal band 4.1 /JEF domain may contribute to its regulation by interacting with integrins or other as-yet unidentified molecules (Fig. 5c) .
To date, the only known tyrosine kinase closely related to FAK is proline rich-tyrosine kinase 2 (PYK2) (104), also named cell adhesion kinase (3 (CAK(3) (105) , related adhesion focal tyrosine kinase (RAFTK) (106) , Ca2 +-dependent tyrosine kinase (CADTK) (107), or FAK2 (108). PYK2 displays a high degree of sequence similarity with FAK over most of its sequence. However, the focal targeting properties of PYK2 appear to be repressed in most circumstances (109) . Src-family kinases interact with PYK2 following its autophosphorylation on a tyrosine residue (Tyr-402) corresponding to the autophosphorylation site of FAK (110) . Although the partners and activation of PYK2 have not been as extensively studied as those of FAK, there are striking similarities and some differences between the two kinases (96) . One characteristic of PYK2 is its sensitivity to increased free intracellular Ca21 (104, 107) , at least in part mediated by protein kinase C ( 1 1-1 14) . The band 4.1 /JEF domain most closely related to that of FAK and PYK2 is found in KIAA0316, a predicted open reading frame that contains an N-terminal PDZ domain and a long C-terminal region of unknown function ( Figs. 1 and 3 ; see above).
The JAK Family The JAK tyrosine kinases are an important group of nonreceptor tyrosine kinases that associate with the intracytoplasmic region of receptors for a number of cytokines and polypeptidic hormones or growth factors ( 115, 116 The JAKs contain a number of regions in which the residues are conserved among all the members of the JAK family. These regions have been termed JAK-homology regions (JH) and are numbered 1-7, starting from the C terminus (by analogy with the SH domains of the Src family) (115, 116) . JH1 is the tyrosine kinase domain. JH2 is a kinase-like domain that appears to be important for the function of the JAKs but whose precise role is not known. The N-terminal half of the molecule comprising JH3-7 is far less characterized. The region surrounding JH3 has been shown to possess the structural features of a SH2 domain (117) . However, no ligand for this SH2-like domain has yet been identified. The N-terminal region of JAKs, corresponding to the band 4.1 /Jef domain (15) , is responsible for their interaction with the receptors and the specificity of this interaction (115, 116) (Fig. 5d) . Interestingly, the N-terminal limit of the region of Tyk2 necessary for interaction with the interferon a/X3 receptor (118) corresponds to the limit of the band 4.1 /JEF domain. Thus, the N-terminal half of JAKs contains two welldefined globular domains, a band 4.1 /JEF domain, and a SH2-like domain. The most Nterminal region (corresponding to the first subdomain of band 4.1 /JEF domain and the hinge region, see above) is primarily involved in the binding to the receptor (118) . The sequences in tha receptor that interact with the JAKs have not been fully identified. The membrane-proximal region is critical for the binding of JAKs and a short proline-rich sequence (Box 1) appears to contribute to the specification of the JAK isoform that interacts with the receptor (115, (119) (120) (121) This brief overview of the proteins containing band 4.1/JEF domains and of their properties allows us to identify a number of common themes. Obviously, the existence of structural similarities with a low level of sequence identity does not imply that all the functional properties are identical within the superfamily. On the contrary, significant divergence and specialization of the domains are expected. However, it is also likely that some features may be conserved in many members of the superfamily. Thus, information on the most-studied proteins with these domains can be used to generate interesting working hypotheses for the other proteins.
Interactions with the Membrane-Proximal Domain of Transmembrane Proteins Many of the proteins with band 4.1 /JEF domains interact with the cytoplasmic region of proteins having a single transmembrane segment and an intracellular C terminus. In most cases (Fig. 4) as well as in the case of cytokine receptors (see above), the interaction involves the membraneproximal region of the transmembrane protein. Some of these proteins (glycophorin C, neurexin IV, paranodin) share a short region of similarity, with a GNP consensus motif also found in other proteins which are good candidates for binding proteins with band 4.1 /JEF domains (Fig. 4a) . Other proteins (CD44, CD43, ICAM-2, band 3) possess stretches of basic residues (also found in p55) that appear to be important for the interaction with band 4.1 /JEF domains (Fig. 4b) . This suggests that there may be several distinct binding sites on band 4.1 /JEF domains. The careful study of the interactions between the various band 4.1 /JEF domains and their partners is now required to determine the generality and specificity of these interactions and the structure of the regions involved in binding. (54) . They also perform a regulatory role by maintaining the protein in a closed inactive state, until a specific stimulus (e.g., phosphorylation by Rhokinase in the case of ERM proteins) "opens" the protein (43, 45 A second mechanism of regulation of band 4.1 /JEF domains binding to the membrane is the intervention of small GTP-binding proteins of the Rho family. Rho-GTP increases the association of ERMs with CD44 (56). Rho is necessary for FAK activation in response to many stimuli (123, 124) and Rho-GTP induces the phosphorylation of FAK and associated proteins (125) . The mechanism by which Rho exerts its effects is not precisely known. One possibility is that it activates a serine/threonine kinase (Rho-kinase) that phosphorylates ERM proteins' C-terminus, relieving their intramolecular inhibition (57) . It has also been suggested that Rho-GTP might activate a phosphatidylinositol-5 kinase, thereby increasing the levels of PIP2 (45) . A strong functional relationship between Rho and some proteins with band 4.1/JEF domains is also indicated by the observation that ERM proteins are required for the effects of Rho-GTP on membrane and cytoskeleton (51) . It is noteworthy in this context that the band 4.1 /JEF domains of ERMs can associate with Rho-GDI (50) and that CDEP, a novel protein containing a band 4.1 /JEF domain, has a domain of homology with Rho-GEF (34) .
The properties of proteins with band 4.1 /JEF domains can be regulated by phosphorylation. Phosphorylation sites for several serine/threonine or tyrosine kinases have been reported on many of these proteins, and in some cases shown to alter their properties (57, 121, 126, 127 (129) . The clinical manifestations result from a defect in the cortical cytoskeleton of red blood cells and are similar to those due to mutations in the genes of two proteins associated with band 4.1: spectrin and glycophorin C. A large variety of mutations in the merlin/schwannomin gene are responsible for NF2, which is characterized by the occurrence of multiple schwannomas and meningiomas (130) . Somatic mutations of the NF2 gene are also observed in sporadic schwannomas and mesotheliomas (131, 132) . Schwannomin is absent in many glial tumors as a result of the combination of a germ-line mutation and a somatic mutation in hereditary cases (NF2), or of two somatic mutations in sporadic cases. It is noteworthy that several mutations of merlin/schwannomin identified in human tumors are missense mutations or short deletions in the band 4.1 /JEF domain, emphasizing the functional importance of this domain. The mutation of a third protein with band 4.1 /JEF domain, myosin VIIa, is responsible for hereditary deafness in mice and humans (74) . Mutations in the myosin VIla gene result in shaker-I phenotype in mice and in Usher syndrome type lB in humans. Both diseases include deafness, but patients with Usher syndrome are also blinded by retinitis pigmentosa. It has been hypothesized that myosin VIIa is important for the integrity of the stereocils of the auditory cells and that it may participate in the phagocytosis of photoreceptors by the retinal pigmented epithelium (13 3). In the case of JAK family, at least one point mutation occurring in the N-terminal region of JAK3 has been reported in humans, resulting in a severe combined immunodeficiency (134) . This mutation (Tyr-100 -> Cys) occurs in one of the most conserved stretches of the band 4.1 /JEF domain (block 6), underlining its functional importance. Interestingly, a point deletion in the corresponding position in merlin/schwannomin (Phe-96) has been reported in a case of NF2 (135) . By contrast, a point mutation (Gly-341 -> Glu) in the Drosophila relative to JAKs, Hopscotch, which results in a dominant gain of function with leukemia-like hematopoietic defects, is located in a loop that appears to be specific for this protein (136) .
Thus, although the superfamily of band 4.1/ JEF domains appears to be divergent, the evidence reviewed here suggests that several of their properties have been conserved. We have proposed a number of hypotheses based on this assumption. Experimental approaches, including determination of the three-dimensional structure of representative examples of proteins with this domain, will allow us to test some of these hypotheses.
